ArticleInfection and drug resistance2022
Omadacycline for the Treatment of Severe
Article in Infection and drug resistance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 18 citations in OpenAlex.
- Clinical characteristics and prognosis of patients with Chlamydia psittaci pneumonia identified by metagenomic next-generation sequencing.BMC infectious diseases · 2026Article
- Antimicrobial Management of SevereInfection and drug resistance · 2026Review
- A case report of spherical pneumonia caused byFrontiers in medicine · 2026Article
- Early diagnosis and therapy of Chlamydia psittaci pneumonia: insights from chest CT, tNGS, and omadacycline in 34 cases.Frontiers in medicine · 2026Article
- Clinical Features of 186 Cases ofInfection and drug resistance · 2026Article
- Clinical management and pharmaceutical care of severeFrontiers in cellular and infection microbiology · 2026Review
- Psittacosis in Focus: A Review Addressing the Risks and Management Challenges in Outbreak Scenarios.Health science reports · 2025Article
- Severe pneumonia caused byFrontiers in medicine · 2025Article
- A matched pilot cohort study of intravenous omadacycline in the treatment of severe pneumonia associated with carbapenem-resistantFrontiers in microbiology · 2025Article
- Effectiveness of Omadacycline in a Patient withInfection and drug resistance · 2025Article
- Review
- Case Report of SevereInternational medical case reports journal · 2024Article
- A Case Study of Severe Pneumonia Caused by mixed Infection ofInfection and drug resistance · 2024Article
- Psittacosis Pneumonia Features, Distinguishing Characteristics, and Outcomes: A Retrospective Study.Infection and drug resistance · 2024Article
- Omadacycline for the Treatment of SevereInfection and drug resistance · 2024Article
- Clinical features and risk factors of liver injury in patients withFrontiers in cellular and infection microbiology · 2023Article
- Extracorporeal Membrane Oxygenation in Severe Acute Respiratory Distress Syndrome Caused byInfection and drug resistance · 2023Article
- Chlamydia psittaci-related pleuro-myocarditis.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious DiseasesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Psittacosis is a rare zoonotic disease caused by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.